Skip to main content
Erschienen in: Infection 4/2015

01.08.2015 | Original Paper

Antibiotic consumption after implementation of a procalcitonin-guided antimicrobial stewardship programme in surgical patients admitted to an intensive care unit: a retrospective before-and-after analysis

verfasst von: A. Hohn, B. Heising, S. Hertel, G. Baumgarten, M. Hochreiter, S. Schroeder

Erschienen in: Infection | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To analyse antibiotic use density (AD)—World Health Organization defined daily doses/1,000 patient-days—before and after implementation of a local antimicrobial stewardship programme (ASP) in conjunction with a procalcitonin (PCT)-guided protocol in a surgical intensive care unit (ICU).

Methods

In this retrospective observational study, data on 2,422 ICU patients between 2010 and 2012 were analysed. In 2011, an ASP in conjunction with a PCT protocol had been introduced into clinical practice. In a multivariate analysis, hospital mortality, length of stay (LOS) in hospital and ICU LOS were adjusted for effects from effective cost weight, gender, and age. AD and changes in the use of antibiotic classes were analysed.

Results

AD decreased from 1,005.0 in 2010 to 791.9 in 2012 which is a total reduction of 21.2 %. Consumption of aminoglycosides, cephalosporins and quinolones showed a marked reduction, whereas the use of penicillins did not change significantly. The multivariate models revealed no relevant changes in mortality rate, ICU LOS and hospital LOS.

Conclusions

Implementation of an ASP in conjunction with a PCT protocol in 2011 was associated with a marked decrease in total AD and led to a significant change in the spectrum of antibiotics. Clinical outcomes appeared to remain unchanged over the study period.
Literatur
2.
Zurück zum Zitat Armand-Lefevre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppe E, et al. Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemo. 2013;57:1488–95. doi:10.1128/aac.01823-12.CrossRef Armand-Lefevre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppe E, et al. Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemo. 2013;57:1488–95. doi:10.​1128/​aac.​01823-12.CrossRef
3.
Zurück zum Zitat Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Annals of internal medicine. 2001;134:298–314.PubMedCrossRef Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Annals of internal medicine. 2001;134:298–314.PubMedCrossRef
4.
Zurück zum Zitat Kaki R, Elligsen M, Walker S, Simor A, Palmay L, Daneman N. Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemo. 2011;66:1223–30. doi:10.1093/jac/dkr137.CrossRef Kaki R, Elligsen M, Walker S, Simor A, Palmay L, Daneman N. Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemo. 2011;66:1223–30. doi:10.​1093/​jac/​dkr137.CrossRef
6.
Zurück zum Zitat Kopterides P, Siempos II, Tsangaris I, Tsantes A, Armaganidis A. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2010;38:2229–41. doi:10.1097/CCM.0b013e3181f17bf9.PubMedCrossRef Kopterides P, Siempos II, Tsangaris I, Tsantes A, Armaganidis A. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2010;38:2229–41. doi:10.​1097/​CCM.​0b013e3181f17bf9​.PubMedCrossRef
7.
Zurück zum Zitat Matthaiou DK, Ntani G, Kontogiorgi M, Poulakou G, Armaganidis A, Dimopoulos G. An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients. Int Care Med. 2012;38:940–9. doi:10.1007/s00134-012-2563-7.CrossRef Matthaiou DK, Ntani G, Kontogiorgi M, Poulakou G, Armaganidis A, Dimopoulos G. An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients. Int Care Med. 2012;38:940–9. doi:10.​1007/​s00134-012-2563-7.CrossRef
8.
Zurück zum Zitat Prkno A, Wacker C, Brunkhorst FM, Schlattmann P. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock—a systematic review and meta-analysis. Crit Care. 2013;17:R291. doi:10.1186/cc13157.PubMedCentralPubMedCrossRef Prkno A, Wacker C, Brunkhorst FM, Schlattmann P. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock—a systematic review and meta-analysis. Crit Care. 2013;17:R291. doi:10.​1186/​cc13157.PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Schuetz P, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis. 2012;55:651–62. doi:10.1093/cid/cis464.PubMedCentralPubMedCrossRef Schuetz P, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis. 2012;55:651–62. doi:10.​1093/​cid/​cis464.PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Albrich WC, Dusemund F, Bucher B, Meyer S, Thomann R, Kuhn F, et al. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in “real life”: an International, Multicenter Poststudy Survey (ProREAL). Arch Int Med. 2012;172:715–22. doi:10.1001/archinternmed.2012.770.CrossRef Albrich WC, Dusemund F, Bucher B, Meyer S, Thomann R, Kuhn F, et al. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in “real life”: an International, Multicenter Poststudy Survey (ProREAL). Arch Int Med. 2012;172:715–22. doi:10.​1001/​archinternmed.​2012.​770.CrossRef
13.
Zurück zum Zitat Schuetz P, Batschwaroff M, Dusemund F, Albrich W, Burgi U, Maurer M, et al. Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey. Eur J Clin Microb Infect Dis. 2010;29:269–77. doi:10.1007/s10096-009-0851-0.CrossRef Schuetz P, Batschwaroff M, Dusemund F, Albrich W, Burgi U, Maurer M, et al. Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey. Eur J Clin Microb Infect Dis. 2010;29:269–77. doi:10.​1007/​s10096-009-0851-0.CrossRef
15.
Zurück zum Zitat Meyer E, Jonas D, Schwab F, Rueden H, Gastmeier P, Daschner FD. Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection. 2003;31:208–15.PubMed Meyer E, Jonas D, Schwab F, Rueden H, Gastmeier P, Daschner FD. Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection. 2003;31:208–15.PubMed
18.
Zurück zum Zitat Kuster SP, Ruef C, Bollinger AK, Ledergerber B, Hintermann A, Deplazes C, et al. Correlation between case mix index and antibiotic use in hospitals. J antimicrob chemother. 2008;62:837–42. doi:10.1093/jac/dkn275.PubMedCrossRef Kuster SP, Ruef C, Bollinger AK, Ledergerber B, Hintermann A, Deplazes C, et al. Correlation between case mix index and antibiotic use in hospitals. J antimicrob chemother. 2008;62:837–42. doi:10.​1093/​jac/​dkn275.PubMedCrossRef
19.
Zurück zum Zitat Aldeyab MA, Harbarth S, Vernaz N, Kearney MP, Scott MG, Darwish Elhajji FW, et al. The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings. British J Clin Pharmacol. 2012;74:171–9. doi:10.1111/j.1365-2125.2011.04161.x.CrossRef Aldeyab MA, Harbarth S, Vernaz N, Kearney MP, Scott MG, Darwish Elhajji FW, et al. The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings. British J Clin Pharmacol. 2012;74:171–9. doi:10.​1111/​j.​1365-2125.​2011.​04161.​x.CrossRef
20.
Zurück zum Zitat Dancer SJ, Kirkpatrick P, Corcoran DS, Christison F, Farmer D, Robertson C. Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum beta-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 2013;41:137–42. doi:10.1016/j.ijantimicag.2012.10.013.PubMedCrossRef Dancer SJ, Kirkpatrick P, Corcoran DS, Christison F, Farmer D, Robertson C. Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum beta-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 2013;41:137–42. doi:10.​1016/​j.​ijantimicag.​2012.​10.​013.PubMedCrossRef
21.
Zurück zum Zitat Livermore DM, Hope R, Reynolds R, Blackburn R, Johnson AP, Woodford N. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? J Antimicrob Chemother. 2013;68:2667–74. doi:10.1093/jac/dkt212.PubMedCrossRef Livermore DM, Hope R, Reynolds R, Blackburn R, Johnson AP, Woodford N. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? J Antimicrob Chemother. 2013;68:2667–74. doi:10.​1093/​jac/​dkt212.PubMedCrossRef
22.
Zurück zum Zitat Kaier K, Hagist C, Frank U, Conrad A, Meyer E. Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am. 2009;30:346–53. doi:10.1086/596605.CrossRef Kaier K, Hagist C, Frank U, Conrad A, Meyer E. Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am. 2009;30:346–53. doi:10.​1086/​596605.CrossRef
23.
Zurück zum Zitat Pepin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005;41:1254–60. doi:10.1086/496986.CrossRef Pepin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005;41:1254–60. doi:10.​1086/​496986.CrossRef
24.
Zurück zum Zitat Talpaert MJ. Gopal Rao G, Cooper BS, Wade P. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother. 2011;66:2168–74. doi:10.1093/jac/dkr253.PubMedCrossRef Talpaert MJ. Gopal Rao G, Cooper BS, Wade P. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother. 2011;66:2168–74. doi:10.​1093/​jac/​dkr253.PubMedCrossRef
25.
Zurück zum Zitat Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4:Cd003543. doi:10.1002/14651858.CD003543.pub3. Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4:Cd003543. doi:10.​1002/​14651858.​CD003543.​pub3.
26.
27.
Zurück zum Zitat Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clinical infectious diseases : an official publication of the Infectious Diseases Society of. America. 1999;29:245–52. doi:10.1086/520193. Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clinical infectious diseases : an official publication of the Infectious Diseases Society of. America. 1999;29:245–52. doi:10.​1086/​520193.
28.
Zurück zum Zitat Rhomberg PR, Jones RN, Sader HS. Results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: report of the 2001 data from 15 United States medical centres. Int J Antimicrob Agents. 2004;23:52–9.PubMedCrossRef Rhomberg PR, Jones RN, Sader HS. Results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: report of the 2001 data from 15 United States medical centres. Int J Antimicrob Agents. 2004;23:52–9.PubMedCrossRef
29.
Metadaten
Titel
Antibiotic consumption after implementation of a procalcitonin-guided antimicrobial stewardship programme in surgical patients admitted to an intensive care unit: a retrospective before-and-after analysis
verfasst von
A. Hohn
B. Heising
S. Hertel
G. Baumgarten
M. Hochreiter
S. Schroeder
Publikationsdatum
01.08.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 4/2015
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-014-0718-x

Weitere Artikel der Ausgabe 4/2015

Infection 4/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.